Nigeria Approves AstraZeneca Vaccines for Emergency Use
- Regulator is evaluating three other virus shots, 30 medicines
- Government bought 16 million AstraZeneca doses through Covax
This article is for subscribers only.
Nigerian regulators approved a coronavirus vaccine that was developed by AstraZeneca Plc and the University of Oxford for emergency use in the West African nation.
“The Serum Institute of India Ltd. on Feb. 10 submitted a dossier on the Covishield vaccine, which it is producing under license from AstraZeneca, and it was found to be safe and well-tolerated in adults above 18 years of age, the National Agency for Food and Drug Administration and Control said in a statement on Thursday.